Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Akoustis Technologies, Inc.AKTS · Entity 88229 | Director · Chief Executive Officer | January 29, 2024 | January 31, 2024 |
| Blue Laser Fusion, Inc.NONE · Entity 107871 | Director | September 30, 2026 | October 05, 2026 |
| Palomino Laboratories Inc.NONE · Entity 9910 | Director · President and CEO · 10% owner | September 29, 2025 | October 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Akoustis Technologies, Inc.
Report date January 29, 2024 · Filed January 31, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,222,775 |
Reported balance
After 2024-01-29 transaction · row 1
1 source rowRow 1 · 2024-01-29 · Purchase · Acquired 1,310,000 · Balance 2,222,775 F1: Represents shares of Common Stock purchased by the reporting person at the public offering price in connection with the issuer's underwritten public offering of Common Stock, which closed on January 29, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock purchased by the reporting person at the public offering price in connection with the issuer's underwritten public offering of Common Stock, which closed on January 29, 2024.
Blue Laser Fusion, Inc.
Report date September 30, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,637 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Other · Acquired 3,637 · Balance 3,637 F1: Pursuant to a subscription agreement, the Reporting Person and Erika C. Cerini Honick purchased 3,637 shares of common stock of the Issuer in the second closing of the Issuer's private placement offering at a price of $27.50 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to a subscription agreement, the Reporting Person and Erika C. Cerini Honick purchased 3,637 shares of common stock of the Issuer in the second closing of the Issuer's private placement offering at a price of $27.50 per share.
Palomino Laboratories Inc.
Report date September 29, 2025 · Filed October 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,666,666 |
Reported balance
After 2025-09-29 transaction · row 1
1 source rowRow 1 · 2025-09-29 · Other · Acquired 3,833,333 · Balance 4,666,666 F1: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.50 | Direct | 4,666,666 |
Reported balance
After 2025-09-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-09-29 · Sale · Acquired 833,333 · Balance 4,666,666 F1: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2019 Filed Nov 27, 2019 17:23 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 25,000 | $7.51 | $187,750.00 |
DisclosureSEC source: 0001562180-19-005764 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,153,562 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2019 (as amended on June 19, 2019). F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 30, 2019 Filed Oct 3, 2019 17:09 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 178 | $7.76 | $1,381.28 |
DisclosureSEC source: 0001562180-19-005103 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 13,314 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 18, 2019. These shares were sold in order to cover the reporting person's tax liability incurred in connection with the vesting of restricted stock units on September 27, 2019. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.61 to $7.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 27, 2019 Filed Sep 30, 2019 17:13 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 7,500 | $7.62 | $57,150.00 |
DisclosureSEC source: 0001562180-19-004970 · primarydocument.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,178,562 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2019 (as amended on June 19, 2019). F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.52 to $7.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 17:13 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 25,000 | $7.77 | $194,250.00 |
DisclosureSEC source: 0001562180-19-004970 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,186,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2019 (as amended on June 19, 2019). F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.60 to $7.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 16:58 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 460 | $7.44 | $3,422.40 |
DisclosureSEC source: 0001562180-19-004690 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · by spouse Disclosed balance after: 13,492 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on June 18, 2019. These shares were sold in order to cover the tax liability of the reporting person's spouse incurred in connection with the vesting of restricted stock units on September 4, 2019. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.44 to $7.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 27, 2019 Filed Jun 28, 2019 18:39 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 7,500 | $5.85 | $43,875.00 |
DisclosureSEC source: 0001562180-19-003679 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,211,062 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2019. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.73 to $6.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 05, 2019 Filed Mar 12, 2019 17:31 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 1,852 | $6.53 | $12,093.56 |
DisclosureSEC source: 0001562180-19-001877 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 13,952 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 19, 2018. These shares were sold in order to cover the reporting person's tax liability incurred in connection with the vesting of restricted stock units on March 2, 2019. Read SEC document |
| November 27, 2018 Filed Nov 27, 2018 18:51 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantStock Options (Right to buy) · Derivative | 40,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001562180-18-004716 · primarydocument.xml · derivative · entry 3 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2025-11-26 F2 · derivative.exercise_date: The Stock Options vest in four equal annual installments beginning on November 27, 2019. Read SEC document |
| November 27, 2018 Filed Nov 27, 2018 18:51 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-18-004716 · primarydocument.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218,562 Read SEC document |
| November 23, 2018 Filed Nov 27, 2018 18:51 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantStock Options (Right to buy) · Derivative | 5,000 | $0.00 Strike: $4.76 | $0.00 |
DisclosureSEC source: 0001562180-18-004716 · primarydocument.xml · derivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2025-11-22 F1 · derivative.exercise_date: The Stock Options vest in four equal annual installments beginning on November 23, 2019. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 19:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 196 | $4.80 | $940.80 |
DisclosureSEC source: 0001615774-18-012595 · ownership.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 15,804 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's wife on September 19, 2018. The shares were sold in order to cover the reporting person's tax liability incurred in connection with the vesting of restricted stock units on September 27, 2018. Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 06:08 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 3,000 | $8.26 | $24,780.00 |
DisclosureSEC source: 0001615774-18-010234 · s112981_form4.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,198,562 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 19, 2018. These shares were sold in order to cover the reporting person's tax liability incurred in connection with the vesting of restricted stock units on September 27, 2018. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.40, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2018 Filed Sep 4, 2018 18:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-009111 · s112506_form4.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 16,000 Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 18:21 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 7,200 | $7.67 | $55,224.00 |
DisclosureSEC source: 0001615774-18-008177 · s112103_form4.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,201,562 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 19, 2018. The shares were sold to fund federal and state individual tax obligations. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.47 to $7.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 18:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-001640 · s109250_form4.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 11,000 Read SEC document |
| February 23, 2018 Filed Feb 23, 2018 18:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 17,100 | $6.28 | $107,388.00 |
DisclosureSEC source: 0001615774-18-001441 · s109178_form4.xml · nonDerivative · entry 3 Shealy Jeffrey B. · CIK 0001700683 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,208,762 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 18:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 40,000 | $6.59 | $263,600.00 |
DisclosureSEC source: 0001615774-18-001441 · s109178_form4.xml · nonDerivative · entry 2 Shealy Jeffrey B. · CIK 0001700683 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,225,862 F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.33 to $6.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 18:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 40,000 | $6.87 | $274,800.00 |
DisclosureSEC source: 0001615774-18-001441 · s109178_form4.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,265,862 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.76 to $7.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 20, 2017 Filed Dec 22, 2017 17:01 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 24,863 | $5.94 | $147,686.22 |
DisclosureSEC source: 0001615774-17-007574 · s108525_form4.xml · nonDerivative · entry 1 Shealy Jeffrey B. · CIK 0001700683 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,305,862 F1 · shares: Shares sold to fund federal and state individual tax obligations. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.90 to $6.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 16:36 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001615774-17-005472 · s107636_form4.xml · derivative · entry 2 Shealy Jeffrey · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2024-09-26 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on September 27, 2018. Read SEC document |
| September 27, 2017 Filed Sep 29, 2017 16:36 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-17-005472 · s107636_form4.xml · nonDerivative · entry 1 Shealy Jeffrey · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,330,725 Read SEC document |
| September 27, 2017 Filed Dec 18, 2017 16:01 UTC Amendment | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001615774-17-007409 · s108464_form4.xml · derivative · entry 2 Shealy Jeffrey · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2024-09-26 F1 · shares: This transaction was omitted from the reporting person's original Form 4, and the holdings of the reporting person's wife were omitted from the reporting person's Form 4 filed June 6, 2017. F2 · derivative.exercise_date: The option vests in four equal annual installments beginning on September 27, 2018. Read SEC document |
| September 27, 2017 Filed Dec 18, 2017 16:01 UTC Amendment | Akoustis Technologies, Inc. AKTS · Entity 88229 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-17-007409 · s108464_form4.xml · nonDerivative · entry 1 Shealy Jeffrey · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 6,000 F1 · shares: This transaction was omitted from the reporting person's original Form 4, and the holdings of the reporting person's wife were omitted from the reporting person's Form 4 filed June 6, 2017. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:00 UTC | Akoustis Technologies, Inc. AKTS · Entity 88229 | SaleCommon Stock | 185,861 | $8.81 | $1,637,435.41 |
DisclosureSEC source: 0001615774-17-002985 · s106473_form4.xml · nonDerivative · entry 1 Shealy Jeffrey · CIK 0001700683 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,300,725 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.65 to $9.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.